LumediX Company
.png)
LumediX develops nanoparticles to enhance immunoassay sensitivity.
Industry:
Medical Device, Nanotechnology
Headquarters:
European Union (EU)
Founded Date:
2018-01-01
Employees Number:
11-50
Last Funding Date:
2018
Last Funding Type:
Non-equity Assistance
Register and Claim Ownership